Posted in Arthritis, Joint Pain, Pain on 03/10/2010 05:15 pm by admin
Reuters - It may not be surprising, but a new study offers some proof that patients who are worried about their medications are more likely to have side effects from them.
Y! Health Arthritis News posted:
Reuters - It may not be surprising, but a new study offers some proof that patients who are worried about their medications are more likely to have side effects from them.
Medication fears lead to worse side effects (Reuters)
Posted in Arthritis, Joint Pain, Pain on 03/10/2010 05:15 pm by admin
Reuters - It may not be surprising, but a new study offers some proof that patients who are worried about their medications are more likely to have side effects from them.
Y! Health Arthritis News posted:
Reuters - It may not be surprising, but a new study offers some proof that patients who are worried about their medications are more likely to have side effects from them.
Get more from Y! Health Arthritis News
Roche, Biogen suspends arthritis drug after deaths (Reuters)
Posted in Arthritis, Joint Pain, Pain on 03/09/2010 12:15 pm by admin
Reuters - Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting doubt over its future.
Y! Health Arthritis News posted:
Reuters - Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting doubt over its future.
Get more from Y! Health Arthritis News
Roche, Biogen suspends arthritis drug after deaths (Reuters)
Posted in Arthritis, Joint Pain, Pain on 03/09/2010 12:15 pm by admin
Reuters - Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting doubt over its future.
Y! Health Arthritis News posted:
Reuters - Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting doubt over its future.
Get more from Y! Health Arthritis News